CLPTClearPoint Neuro, Inc.

Nasdaq clearpointneuro.com


$ 5.18 $ -0.05 (-0.94 %)    

Friday, 26-Apr-2024 15:51:47 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 5.26
$ 5.39
$ 0.00 x 0
$ 0.00 x 0
$ 5.17 - $ 5.40
$ 4.05 - $ 10.80
168,814
na
129.42M
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-12-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-08-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-22-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-13-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-21-2018 12-31-2017 10-K
26 11-06-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-09-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 03-25-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-17-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clearpoint-neuro-congratulates-its-partner-aviadobio-on-first-patient-treated-in-its-aspire-ftd-clinical-trial-evaluating-avb-101-for-frontotemporal-dementia-with-grn-mutations

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

 clearpoint-neuro-congratulates-its-partner-ptc-therapeutics-on-completion-of-biologics-license-application-submission-to-fda-for-upstaza-as-a-treatment-for-aadc-deficiency

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

 stifel-reiterates-buy-on-clearpoint-neuro-raises-price-target-to-9

Stifel analyst Mathew Blackman reiterates ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $8 to $9.

 clearpoint-neuro-q4-2023-gaap-eps-019-beats-020-estimate-sales-6810m-beat-6533m-estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

 earnings-scheduled-for-march-12-2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

 journal-of-neurosurgery-publication-demonstrates-advantages-of-clearpoint-prism-neuro-laser-therapy-system

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

 clearpoint-neuro-announces-fda-clearance-and-first-in-human-cases-performed-with-the-new-22-software-version-and-the-integrated-maestro-brain-model

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

 clearpoint-neuro-announces-installation-and-first-procedure-using-the-clearpoint-prism-neuro-laser-therapy-system-and-navigation-system-at-kaleida-health-in-buffalo

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

 clearpoint-neuro-reveals-receipt-of-european-medical-device-regulation-clearance-for-the-manual-smarttwist-mr-hand-drill-and-smarttip-mr-drill-kit

Additionally, the company received updated certification from its Notified Body allowing for shipment of products manufactured ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION